About Us

General BioTechnology LLC (GBT) was founded in 1997 by former Indiana University School of Medicine researchers. The company was initially based on novel technologies including methods and devices specifically related to giving biological cells and tissues shelf life.

General BioTechnology LLC has been awarded several SBIR grants to improve the cryopreservation and banking methods of such diverse cell and tissue types, human pancreatic islets of Langerhans, blood platelets, umbilical cord blood, peripheral blood stem cells and spermatozoa.

The company has also won contracts with several other biotechnology companies as well as various universities to aid in development of cryopreservation and banking procedures for "fragile" unique cell and tissue types. Research sponsored by these programs has resulted in the development of several patents directly assigned to GBT and several others licensed back related to cryopreservation processing.

Presently, GBT also runs a commercial cord blood bank (The Genesis Bank) and an anonymous donor and autologous sperm bank (Genome Resources).